Audiologists have known about the ototoxicity of quinine (and its derivatives) and antibiotics (macrolide and aminoglycoside) for decades. But we have never seen the combined use of two drugs, each with known ototoxic potential, being used as an intervention strategy for the coronavirus pandemic (COVID-19).
In an effort to combat the coronavirus (COVID-19), front-line physicians are repurposing two drugs: hydroxychloroquine (commonly used for malaria and rheumatoid arthritis) and azithromycin (a macrolide antibiotic used to treat common infections of the respiratory system, the ear and the eye). Both drugs are known ototoxic agents; however, there is no published research about the synergistic ototoxic effects of these drugs in treating COVID-19.
At the present time, it is not known if hearing loss and/or tinnitus will be a late onset side effect of this COVID-19 drug intervention. Therefore, case history questions will need to be added to accommodate this new population of patients.
Related Posts
“Huh?” Is More Than an Interrogatory Palindrome!
“Huh?” is used in at least 31 languages around the world! A version of the word can be found in nearly every language on Earth (Dingemanse et al, 2013). This research concluded that all languages studied included a word similar, in both sound and function, to the English “huh?” Regardless of language, the word is…
Another Useless Body Part…
If you have a dog or cat, you’ve probably seen their ears moving toward an interesting or startling sound. For professional equestrians, watching the ears of their horse allows them to gauge their shifting attention. Humans still have these same muscles, and even more interesting is their relationship to our brain and how we pay attention. …
Memorizing Movements: How Tai Chi Can Improve Balance and Cognition
Tai Chi is not just for increasing balance; it may also help improve cognitive performance. In a recent randomized controlled trial, study participants who practiced a form of Tai Chi twice a week for six months improved their scores on the Montreal Cognitive Assessment (MoCA) when compared to a control group (Fuzhong et al, 2023)….